McEachin Introduces Legislation Addressing Patient Safety Gap In Generic Drug Labeling
September 27, 2022
September 27, 2022
WASHINGTON, Sept. 27 -- Rep. A. Donald McEachin, D-Virginia, issued the following news release:
Congressman A. Donald McEachin (VA-04) introduced the Updated Drug Labeling for Patient Safety Act, legislation to direct the Food and Drug Administration (FDA) to allow generic drug manufacturers to update their product labeling with safety-related information.
Current FDA regulations require a generic drug to have the same labeling as its brand-name counterpart with very li . . .
Congressman A. Donald McEachin (VA-04) introduced the Updated Drug Labeling for Patient Safety Act, legislation to direct the Food and Drug Administration (FDA) to allow generic drug manufacturers to update their product labeling with safety-related information.
Current FDA regulations require a generic drug to have the same labeling as its brand-name counterpart with very li . . .